Author:
Fülöp G.,Domokos A.,Galata D.,Szabó E.,Gyürkés M.,Szabó B.,Farkas A.,Madarász L.,Démuth B.,Lendér T.,Nagy T.,Kovács-Kiss D.,Van der Gucht F.,Marosi G.,Nagy Z.K.
Funder
Hungarian Scientific Research Fund
Reference68 articles.
1. Changing R&D models in research-based pharmaceutical companies;Schuhmacher;J. Translational Medicine,2016
2. Michalopoulos, S. Lawmakers warn EU pharma industry about drug pricing. Available online: https://www.euractiv.com/section/health-consumers/news/lawmakers-warn-eu-pharma-industry-about-drugs-pricing/ (accessed on 12 September 2018).
3. Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen;Badman;J. Pharm. Sci.,2019
4. Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study;Schaber;Ind. Eng. Chem. Res.,2011
5. Regulatory and Quality Considerations for Continuous Manufacturing May 20–21, 2014 Continuous Manufacturing Symposium;Allison;J. Pharm. Sci.,2015
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献